These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36563966)

  • 21. Female mice are resilient to age-related decline of substantia nigra dopamine neuron firing parameters.
    Howell RD; Dominguez-Lopez S; Ocañas SR; Freeman WM; Beckstead MJ
    Neurobiol Aging; 2020 Nov; 95():195-204. PubMed ID: 32846275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substantia nigra control of basal ganglia nuclei.
    Guatteo E; Cucchiaroni ML; Mercuri NB
    J Neural Transm Suppl; 2009; (73):91-101. PubMed ID: 20411770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.
    Counihan TJ; Penney JB
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):164-9. PubMed ID: 9703165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of the neuronal firing patterns in the subthalamic nucleus with graded dopaminergic cell loss in the nigrostriatal pathway.
    Park SE; Song KI; Suh JK; Youn I
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2510-3. PubMed ID: 26736802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.
    Sloan M; Alegre-Abarrategui J; Potgieter D; Kaufmann AK; Exley R; Deltheil T; Threlfell S; Connor-Robson N; Brimblecombe K; Wallings R; Cioroch M; Bannerman DM; Bolam JP; Magill PJ; Cragg SJ; Dodson PD; Wade-Martins R
    Hum Mol Genet; 2016 Mar; 25(5):951-63. PubMed ID: 26744332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction.
    Darbinyan LV; Simonyan KV; Hambardzumyan LE; Manukyan LP; Badalyan SH; Sarkisian VH
    Metab Brain Dis; 2022 Apr; 37(4):1111-1118. PubMed ID: 35239141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
    Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
    J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in firing rate and pattern of GABAergic neurons in subregions of the substantia nigra pars reticulata in rat models of Parkinson's disease.
    Wang Y; Zhang QJ; Liu J; Ali U; Gui ZH; Hui YP; Chen L; Wang T
    Brain Res; 2010 Apr; 1324():54-63. PubMed ID: 20149784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Regulation of Action Potential Shape and Burst-Frequency Firing by BK and Kv2 Channels in Substantia Nigra Dopaminergic Neurons.
    Kimm T; Khaliq ZM; Bean BP
    J Neurosci; 2015 Dec; 35(50):16404-17. PubMed ID: 26674866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis.
    Plum S; Helling S; Theiss C; Leite REP; May C; Jacob-Filho W; Eisenacher M; Kuhlmann K; Meyer HE; Riederer P; Grinberg LT; Gerlach M; Marcus K
    J Proteomics; 2013 Dec; 94():202-206. PubMed ID: 23917253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal Firing and Glutamatergic Synapses in the Substantia Nigra Pars Reticulata of LRRK2-G2019S Mice.
    Sitzia G; Skiteva O; Chergui K
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemispheric asymmetries in spontaneous firing characteristics of substantia nigra pars reticulata neurons following a unilateral 6-hydroxydopamine lesion of the rat nigrostriatal pathway.
    Rohlfs A; Nikkhah G; Rosenthal C; Rundfeldt C; Brandis A; Samii M; Löscher W
    Brain Res; 1997 Jul; 761(2):352-6. PubMed ID: 9252038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology.
    Prunell G; Olivera-Bravo S
    Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced Dopaminergic Neurons for Parkinson's Disease Therapy: Targeting the Striatum or Midbrain/Substantia Nigra Pars Compacta?
    Xu H; Cheng X; Song Q; Yang Y; Wang C; Kang X
    Neurosci Bull; 2022 Jul; 38(7):820-824. PubMed ID: 35195854
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.
    Brown MT; Henny P; Bolam JP; Magill PJ
    J Neurosci; 2009 Mar; 29(9):2915-25. PubMed ID: 19261887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
    Mercuri NB; Calabresi P; Bernardi G
    Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.